CDC42 Suppression Blocks Leukemia Progression in Preclinical Tests Researchers have hunted for years to find ways to disrupt the uncanny survival and self-renewal abilities of acute myeloid leukemia (AML) cells. So far, experts have found very few specific signaling pathways that lead to a weakness that can be therapeutically exploited.
Read Featured ResearchResearch and Training Details | |
---|---|
Faculty | 26 |
Joint Appointment Faculty | 2 |
Research Fellows and Post Docs | 4 |
Research Graduate Students | 3 |
Total Annual Grant Award Dollars | $3,191,974 |
Total Annual Industry Award Dollars | $2,281,245 |
Clinical Activities and Training | |
---|---|
Staff Physicians | 6 |
Clinical Fellows | 9 |
Inpatient Encounters | 1,229 |
Outpatient Encounters | 16,108 |